Lights and Shadows on Managing Immune Checkpoint Inhibitors in Oncology during the COVID-19 Era
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lights and Shadows on Managing Immune Checkpoint Inhibitors in Oncology during the COVID-19 Era
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 8, Pages 1906
Publisher
MDPI AG
Online
2021-04-16
DOI
10.3390/cancers13081906
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis
- (2021) Maria Antonietta Isgrò et al. Journal of Translational Medicine
- The Treatment and Outcome of a Lung Cancer Patient Infected with SARS-CoV-2
- (2020) Hongyan Zhang et al. Journal of Thoracic Oncology
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS‐CoV‐2
- (2020) Brendan O'Kelly et al. BRITISH JOURNAL OF HAEMATOLOGY
- Functional exhaustion of antiviral lymphocytes in COVID-19 patients
- (2020) Meijuan Zheng et al. Cellular & Molecular Immunology
- The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system
- (2020) Francesca Coperchini et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Clinical Characteristics and Outcome for Four SARS-CoV-2-infected Cancer Patients Treated with Immune Checkpoint Inhibitors
- (2020) Bernadett Szabados et al. EUROPEAN UROLOGY
- Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors
- (2020) Melissa Bersanelli Immunotherapy
- Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis
- (2020) Zhaohai Zheng et al. JOURNAL OF INFECTION
- COVID‐19 in a melanoma patient under treatment with checkpoint‐inhibition
- (2020) P Schmidle et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Coronavirus Disease 2019 or Lung Cancer: What Should We Treat?
- (2020) Marco Russano et al. Journal of Thoracic Oncology
- COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
- (2020) Lennard Y W Lee et al. LANCET
- Immune checkpoint inhibitors in SARS-CoV-2 infected cancer patients: the spark that ignites the fire?
- (2020) Vincenzo Di Noia et al. LUNG CANCER
- Cytokine release syndrome in severe COVID-19
- (2020) John B. Moore et al. SCIENCE
- Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak
- (2020) Mengyuan Dai et al. Cancer Discovery
- Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers
- (2020) Jia Luo et al. Cancer Discovery
- Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Bo Diao et al. Frontiers in Immunology
- Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab
- (2020) Emre Yekedüz et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China
- (2020) Jing Yu et al. JAMA Oncology
- Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
- (2020) Jing Liu et al. EBioMedicine
- COVID-19 Infection in Cancer Patients: How Can Oncologists Deal With These Patients?
- (2020) Oronzo Brunetti et al. Frontiers in Oncology
- Managing cancer patients during the COVID-19 pandemic: An ESMO Interdisciplinary Expert Consensus
- (2020) G. Curigliano et al. ANNALS OF ONCOLOGY
- Immune Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era
- (2020) Michele Maio et al. CLINICAL CANCER RESEARCH
- A moonshot approach toward the management of cancer patients in the COVID-19 time: what have we learned and what could the Italian network of cancer centers (Alliance Against Cancer, ACC) do after the pandemic wave?
- (2020) Nicola Silvestris et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Atypical Skin Manifestations During Immune Checkpoint Blockage in Coronavirus Disease 2019–Infected Patients With Lung Cancer
- (2020) Christian Rolfo et al. Journal of Thoracic Oncology
- COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
- (2020) Marina Chiara Garassino et al. LANCET ONCOLOGY
- Coronaviruses pathogenesis, comorbidities and multi-organ damage – A review
- (2020) Kaviyarasi Renu et al. LIFE SCIENCES
- Determinants of COVID-19 disease severity in patients with cancer
- (2020) Elizabeth V. Robilotti et al. NATURE MEDICINE
- Cancer Management during COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial?
- (2020) Silvia Vivarelli et al. Cancers
- On the Management of Drug Interactions in the Course of Concomitant Treatments for COVID-19 and Antineoplastic Agents
- (2020) Nicola Silvestris et al. Frontiers in Oncology
- Clinical outcomes of coronavirus disease 2019 (COVID‐19) in cancer patients with prior exposure to immune checkpoint inhibitors
- (2020) Qiuji Wu et al. Cancer Communications
- Optimal Management of Neutropenic Fever in Patients With Cancer
- (2019) Andrea J. Zimmer et al. Journal of Oncology Practice
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Pneumonitis in Non-Small Cell Lung Cancer patients receiving Immune Checkpoint Immunotherapy: incidence and risk factors
- (2018) Karthik Suresh et al. Journal of Thoracic Oncology
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy
- (2017) Jarushka Naidoo et al. JOURNAL OF CLINICAL ONCOLOGY
- Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor Therapy
- (2017) Vivek Kumar et al. Frontiers in Pharmacology
- Blocking the Natural Killer Cell Inhibitory Receptor NKG2A Increases Activity of Human Natural Killer Cells and Clears Hepatitis B Virus Infection in Mice
- (2012) Fenglei Li et al. GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now